Pediatric Hematology/Oncology (AREKEN) Osaka Univ Grad School Med

We are treating children with cancer and hematological disorder at Osaka University Hospital, Japan.
Contact us at areken@ped.med.osaka-u.ac.jp

Thursday, June 26, 2008

Morning Seminar June 26, 2008

Bone Marrow Transplant. 2008 Mar;41(5):495-503.
Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant.
Shaw BE, Russell NH.

Tuesday, June 24, 2008

Morning Seminar June 24, 2008

Clin Microbiol Rev. 2004 Oct;17(4):697-728
Mycoplasma pneumoniae and its role as a human pathogen.
Waites KB, Talkington DF.

Friday, June 20, 2008

Morning Seminar June 20, 2008

J Clin Oncol. 2002 Jun 15;20(12):2768-73.
Role of chest computed tomography at diagnosis in the management of Wilms' tumor: a study by the United Kingdom Children's Cancer Study Group.
Owens CM, Veys PA, Pritchard J, Levitt G, Imeson J, Dicks-Mireaux C.

Thursday, June 19, 2008

Morning Seminar June 19, 2008

J Pediatr. 2004 May;144(5):666-8.
Neurofibromatosis in children with Rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma study IV.
Sung L, Anderson JR, Arndt C, Raney RB, Meyer WH, Pappo AS.

Cancer. 2007 Apr 1;109(7):1406-12.
Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1.
Ferrari A, Bisogno G, Macaluso A, Casanova M, D'Angelo P, Pierani P, Zanetti I, Alaggio R, Cecchetto G, Carli M.

Tuesday, June 10, 2008

Morning Seminar June 10, 2008

Pediatr Blood Cancer. 2008 Jul;51(1):23-8.
Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology.
Spreafico F, Bisogno G, Collini P, Jenkner A, Gandola L, D'Angelo P, Casazza G, Piva L, Luksch R, Perotti D, Pession A, Fagioli F, Dallorso S.

Tuesday, June 03, 2008

Morning Seminar June 3, 2008

Pediatr Transplant. 2008 Apr 6. [Epub ahead of print]
A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.
Yabe M, Sako M, Yabe H, Osugi Y, Kurosawa H, Nara T, Tokuyama M, Adachi S, Kobayashi C, Yanagimachi M, Ohtsuka Y, Nakazawa Y, Ogawa C, Manabe A, Kojima S, Nakahata T; Japanese Childhood MDS Study Group.